Promising Publication: The Novel Schizophrenia Treatment Gaining Traction

March 10, 2021

Data published in The New England Journal of Medicine shows promise for a novel schizophrenia treatment.

Stephen Brannan, MD, Chief Medical Officer of Karuna Therapeutics, talks more on the phase II clinical data for KarXT, published in the New England Journal of Medicine.

Dr Brannan is chief medical officer at Karuna Therapeutics and a neuroscience drug development expert.